sulunz Gillead bought a compound in same arena as BIT Hep C market , they achieved 85 % success in clinical three trials , we achieved similar result in clinical 2 trials , Gilleads product since , has not been as successful as anticipated their packaging now caries scull and cross bones as it can kill in very certain circumstances . We do not have those side effects . Our product I would suggest is probably better , but we came to the market with testing too late and were not quick enough . Timing on HIV is a lot better
50 cents On the Horizon ?, page-6
-
- There are more pages in this discussion • 1,701 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
-0.003(9.09%) |
Mkt cap ! $27.06M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.4¢ | 3.0¢ | $32.26K | 1.016M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 720804 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |